120 related articles for article (PubMed ID: 11966980)
1. Analogs of Substance P modified at the C-terminus which are both agonist and antagonist of the NK-1 receptor depending on the second messenger pathway.
Sachon E; Girault-Lagrange S; Chassaing G; Lavielle S; Sagan S
J Pept Res; 2002 May; 59(5):232-40. PubMed ID: 11966980
[TBL] [Abstract][Full Text] [Related]
2. The use of photolabelled peptides to localize the substance-P-binding site in the human neurokinin-1 tachykinin receptor.
Girault S; Sagan S; Bolbach G; Lavielle S; Chassaing G
Eur J Biochem; 1996 Aug; 240(1):215-22. PubMed ID: 8797856
[TBL] [Abstract][Full Text] [Related]
3. Cgamma H2 of Met174 side chain is the site of covalent attachment of a substance P analog photoactivable in position 5.
Sachon E; Bolbach G; Chassaing G; Lavielle S; Sagan S
J Biol Chem; 2002 Dec; 277(52):50409-14. PubMed ID: 12393913
[TBL] [Abstract][Full Text] [Related]
4. Asymmetric synthesis of Boc-N-methyl-p-benzoyl-phenylalanine. Preparation of a photoreactive antagonist of substance P.
Karoyan P; Sagan S; Clodic G; Lavielle S; Chassaing G
Bioorg Med Chem Lett; 1998 Jun; 8(11):1369-74. PubMed ID: 9871768
[TBL] [Abstract][Full Text] [Related]
5. Met174 side chain is the site of photoinsertion of a substance P competitive peptide antagonist photoreactive in position 8.
Sachon E; Bolbach G; Lavielle S; Karoyan P; Sagan S
FEBS Lett; 2003 Jun; 544(1-3):45-9. PubMed ID: 12782288
[TBL] [Abstract][Full Text] [Related]
6. The common C-terminal sequences of substance P and neurokinin A contact the same region of the NK-1 receptor.
Bremer AA; Leeman SE; Boyd ND
FEBS Lett; 2000 Dec; 486(1):43-8. PubMed ID: 11108840
[TBL] [Abstract][Full Text] [Related]
7. Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors.
Sagan S; Chassaing G; Pradier L; Lavielle S
J Pharmacol Exp Ther; 1996 Mar; 276(3):1039-48. PubMed ID: 8786533
[TBL] [Abstract][Full Text] [Related]
8. Isotope and affinity tags in photoreactive substance P analogues to identify the covalent linkage within the NK-1 receptor by MALDI-TOF analysis.
Sachon E; Tasseau O; Lavielle S; Sagan S; Bolbach G
Anal Chem; 2003 Dec; 75(23):6536-43. PubMed ID: 14640725
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the second extracellular loop (E2) of the neurokinin-1 receptor in the binding of substance P. Photoaffinity labeling and modeling studies.
Lequin O; Bolbach G; Frank F; Convert O; Girault-Lagrange S; Chassaing G; Lavielle S; Sagan S
J Biol Chem; 2002 Jun; 277(25):22386-94. PubMed ID: 11950831
[TBL] [Abstract][Full Text] [Related]
10. Photoaffinity labeling of mutant neurokinin-1 receptors reveals additional structural features of the substance P/NK-1 receptor complex.
Macdonald D; Mierke DF; Li H; Pellegrini M; Sachais B; Krause JE; Leeman SE; Boyd ND
Biochemistry; 2001 Feb; 40(8):2530-9. PubMed ID: 11327875
[TBL] [Abstract][Full Text] [Related]
11. Gastric chief cells possess NK1 receptors which mediate pepsinogen secretion and are regulated by agents that increase cAMP and phospholipase C.
Kitsukawa Y; Turner RJ; Pradhan TK; Jensen RT
Biochim Biophys Acta; 1996 Jun; 1312(2):105-16. PubMed ID: 8672532
[TBL] [Abstract][Full Text] [Related]
12. Evidence for spatial proximity of two distinct receptor regions in the substance P (SP)*neurokinin-1 receptor (NK-1R) complex obtained by photolabeling the NK-1R with p-benzoylphenylalanine3-SP.
Bremer AA; Leeman SE; Boyd ND
J Biol Chem; 2001 Jun; 276(25):22857-61. PubMed ID: 11294866
[TBL] [Abstract][Full Text] [Related]
13. Direct evidence for the interaction of neurokinin A with the tachykinin NK(1) receptor in tissue.
Bremer AA; Tansky MF; Wu M; Boyd ND; Leeman SE
Eur J Pharmacol; 2001 Jul; 423(2-3):143-7. PubMed ID: 11448478
[TBL] [Abstract][Full Text] [Related]
14. High affinity binding of [3H]propionyl-[Met(O2)11]substance P(7-11), a tritiated septide-like peptide, in Chinese hamster ovary cells expressing human neurokinin-1 receptors and in rat submandibular glands.
Sagan S; Beaujouan JC; Torrens Y; Saffroy M; Chassaing G; Glowinski J; Lavielle S
Mol Pharmacol; 1997 Jul; 52(1):120-7. PubMed ID: 9224821
[TBL] [Abstract][Full Text] [Related]
15. Incorporation of vinylogous scaffolds in the C-terminal tripeptide of substance P.
Claudel S; Tasseau O; Sagan S; Grison C; Coutrot P; Lavielle S
J Pept Res; 2004 Nov; 64(5):186-93. PubMed ID: 15485556
[TBL] [Abstract][Full Text] [Related]
16. Biological activity of silylated amino acid containing substance P analogues.
Cavelier F; Marchand D; Martinez J; Sagan S
J Pept Res; 2004 Mar; 63(3):290-6. PubMed ID: 15049841
[TBL] [Abstract][Full Text] [Related]
17. Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat.
Wagner U; Fehmann H; Bredenbröker D; Klüber D; Lange A; Wichert P
Neuropeptides; 1999 Feb; 33(1):55-61. PubMed ID: 10657472
[TBL] [Abstract][Full Text] [Related]
18. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
Miike T; Shirahase H; Kanda M; Kunishiro K; Kurahashi K
Vascul Pharmacol; 2009; 51(2-3):147-53. PubMed ID: 19539781
[TBL] [Abstract][Full Text] [Related]
19. Localization of the peptide binding domain of the NK-1 tachykinin receptor using photoreactive analogues of substance P.
Boyd ND; Kage R; Dumas JJ; Silberman SC; Krause JE; Leeman SE
Ann N Y Acad Sci; 1995 May; 757():405-9. PubMed ID: 7541973
[No Abstract] [Full Text] [Related]
20. Characterization of non-peptide antagonist and peptide agonist binding sites of the NK1 receptor with fluorescent ligands.
Turcatti G; Zoffmann S; Lowe JA; Drozda SE; Chassaing G; Schwartz TW; Chollet A
J Biol Chem; 1997 Aug; 272(34):21167-75. PubMed ID: 9261122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
